Navigation path

Pharmaceuticals - Community Register


Community register of veterinary medicinal products


Product information

Invented name: Purevax RCPCh   
Auth. number : EU/2/04/050
Active substance : Not available
ATC: Anatomical main group: QI - Immunologicals
Therapeutic subgroup: QI06 - Immunologicals for felidae
Pharmacological subgroup: QI06A - Cat
Chemical subgroup: QI06AX - Other immunologicals
Chemical substance: QI06AX - Other immunologicals
(See WHO ATCvet Index)
Indication: Active immunisation of cats aged 8 weeks and older:
- against feline viral rhinotracheitis to reduce clinical signs,
- against calicivirus infection to reduce clinical signs and excretion,
- against Chlamydophila felis infection to reduce clinical signs,
- against feline panleucopenia to prevent mortality and clinical signs.
Onsets of immunity have been demonstrated 1 week after primary vaccination course for rhinotracheitis, calicivirus, Chlamydophila felis and panleucopenia components.
The duration of immunity is 1 year after the last (re-)vaccination for rhinotracheitis, calicivirus, and Chlamydophila felis, and 3 years for panleucopenia component.
Marketing Authorisation Holder: Merial
29 avenue Tony Garnier, 69007 Lyon, France
EPAR and active package presentations

Package presentations

Information about presentations can be found in the website of the European Medicines Agency under the section "Product Information".
Likewise, presentations on which there has been a Commission decision are referred in the Summary of Product Characteristics (Annex I to the Commission Decision granting the marketing authorisation) which is available in the Community Register.

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
25/02/2005 Centralised - Authorisation EMEA/V/C/88 (2005)476 of 23/02/2005
18/07/2005 Centralised - Variation (no change in Commission Decision) EMEA/V/C/88/II/1
25/01/2008 Centralised - Variation EMEA/V/C/88/II/2, 3, 4 (2008)329 of 22/01/2008
23/08/2008 Centralised - Variation (no change in Commission Decision) EMEA/V/C/88/II/5
19/02/2009 Centralised - Variation EMEA/V/C/88/II/6 (2009)1180 of 17/02/2009
15/01/2010 Centralised - Renewal EMEA/V/C/88/R/7 (2010)160 of 14/01/2010
30/01/2013 Centralised - Variation EMEA/V/C/88//WS/325/G (2013)530 of 28/01/2013
6/05/2014 Centralised - Variation EMEA/V/C/88/IG/430/11
Updated with Decision(2015)3673 of 27/05/2015
15/01/2015 Centralised - Variation EMEA/V/C/88/WS/606
Updated with Decision(2015)3673 of 27/05/2015
29/05/2015 Centralised - Yearly update (2015)3673 of 27/05/2015